Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-SPARCL1 (17-300) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:1000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
SPARCL1 |
Gene ID: |
8404 |
Uniprot ID: |
SPRL1_HUMAN |
Immunogen Region: |
17-300 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 17-300 of human SPARCL1 (NP_004675.3). |
Immunogen Sequence: |
IPTNARLLSDHSKPTAETVA PDNTAIPSLRAEAEENEKET AVSTEDDSHHKAEKSSVLKS KEESHEQSAEQGKSSSQELG LKDQEDSDGHLSVNLEYAPT EGTLDIKEDMSEPQEKKLSE NTDFLAPGVSSFTDSNQQES ITKREENQEQPRNYSHHQLN RSSKHSQGLRDQGNQEQDPN ISNGEEEEEKEPGEVGTHND NQERKTELPREHANSKQEED NTQSDDILEESDQPTQVSK |
Tissue Specificity | Highly expressed in lymph node, brain, heart, lung, skeletal muscle, ovary, small intestine, and colon, with lower levels in placenta, pancreas, testis, spleen, and thymus, and no expression in kidney, liver, and peripheral blood leukocytes. |
Post Translational Modifications | N- and O-glycosylated. O-glycosylated with a core 1 or possibly core 8 glycan. |
Protein Name | Sparc-Like Protein 1High Endothelial Venule ProteinHevinMast 9 |
Database Links | Reactome: R-HSA-381426Reactome: R-HSA-8957275 |
Cellular Localisation | SecretedExtracellular SpaceExtracellular Matrix |
Alternative Antibody Names | Anti-Sparc-Like Protein 1 antibodyAnti-High Endothelial Venule Protein antibodyAnti-Hevin antibodyAnti-Mast 9 antibodyAnti-SPARCL1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance